- Home
- CFR
as 01-17-2025 4:00pm EST
Cullen/Frost is a regional us bank with around $50 billion in assets (as of 2023 year-end), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.
| Founded: | 1868 | Country: | United States |
| Employees: | N/A | City: | SAN ANTONIO |
| Market Cap: | 8.9B | IPO Year: | N/A |
| Target Price: | $125.38 | AVG Volume (30 days): | 356.3K |
| Analyst Decision: | Hold | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 8.07 | EPS Growth: | -22.98 |
| 52 Week Low/High: | $94.09 - $147.64 | Next Earning Date: | 01-30-2025 |
| Revenue: | $1,964,467,000 | Revenue Growth: | 0.42% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 2.80% |
Latest Cullen/Frost Bankers Inc. News
CFR Breaking Stock News: Dive into CFR Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
CFR: Raising target price to $146.00
Zacks
8 days ago
Cullen/Frost (CFR) Upgraded to Buy: Here's Why
PR Newswire
9 days ago
Cullen/Frost Bankers, Inc. Hosts Fourth Quarter 2024 Earnings Conference Call
Argus Research
a month ago
CFR: Lowering target price to $141.00
Argus Research
a month ago
CFR: Lowering target price to $143.00
Argus Research
a month ago
CFR: Lowering target price to $144.00
Argus Research
a month ago
CFR: Lowering target price to $146.00
Argus Research
2 months ago
CFR: Raising target price to $150.00
Compare CFR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CFR Cullen/Frost Bankers Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.